

[ Fri, Jun 28th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI

[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
[ Thu, Jun 27th 2019
] - WOPRAI
Jason Mills Maintained (BSX) at Strong Buy with Increased Target to $46 on, Jun 27th, 2019
Jason Mills of Canaccord Genuity, Maintained "Boston Scientific Corporation" (BSX) at Strong Buy with Increased Target from $43 to $46 on, Jun 27th, 2019.
Jason has made no other calls on BSX in the last 4 months.
There is 1 other peer that has a rating on BSX. Out of the 1 peers that are also analyzing BSX, 0 agree with Jason's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jason
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $45 on, Tuesday, June 18th, 2019
Contributing Sources